Carpignano Sesia, Italy

Matteo Mossotti


 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Matteo Mossotti: Innovator in Chemical Synthesis

Introduction

Matteo Mossotti is a notable inventor based in Carpignano Sesia, Italy. He has made significant contributions to the field of chemical synthesis, holding 2 patents that showcase his innovative approaches to complex chemical processes.

Latest Patents

One of his latest patents is a process for the synthesis of 2-benzhydryl-3-quinuclidinone. This invention discloses a method for preparing 2-benzhydryl-3-quinuclidinone by reacting 2-benzylidene-3-quinuclidinone with the Grignard reagent phenyl-magnesium halide. The process utilizes catalytic amounts of copper (I) salts, resulting in higher yields compared to known methods. Additionally, the use of less toxic and expensive solvents enhances the efficiency of the process.

Another significant patent is for the synthesis of Pirfenidone. This process involves the reaction of 5-methyl-2(1H)-pyridinone and chlorobenzene in the presence of a catalytic system consisting of a copper salt and an organic ligand. The reaction conditions allow for good yields, making it a valuable contribution to pharmaceutical synthesis.

Career Highlights

Matteo Mossotti is associated with Procos S.p.a., where he applies his expertise in chemical synthesis. His work has led to advancements in the efficiency and safety of chemical processes, making a positive impact in the industry.

Collaborations

He collaborates with talented coworkers such as Jacopo Roletto and Paolo Paissoni, contributing to a dynamic and innovative work environment.

Conclusion

Matteo Mossotti's contributions to chemical synthesis through his patents reflect his commitment to innovation and efficiency in the field. His work continues to influence the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…